Specifically, IBM patients possessed an increased proportion of CD4+ effector memory cells with an inflammatory Th1 T‐bet+ profile and displaying a late‐differentiated phenotype characterised by CD57 upregulation and loss of CD28. The gene discussed is CD28; the disease is inclusion body myositis.